Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02744898 | A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | completed | Phase 2 | 23 | NYU Langone HealthOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT02465541 | Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors | completed | N/A | 16 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT01397877 | GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer(ENDOPIK) | completed | Phase 2 | 24 | ARCAGY/ GINECO GROUPOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05364905 | Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma(ENDOVIE) | completed | — | 200 | ARCAGY/ GINECO GROUPOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT04590248 | A Study of Adavosertib as Treatment for Uterine Serous Carcinoma(ADAGIO) | completed | Phase 2 | 109 | AstraZenecaINDUSTRY | 5 | Aug 14, 2023 | clinicaltrials |
| NCT04705649 | Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer(TAPER) | completed | N/A | 42 | British Columbia Cancer AgencyOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT00053794 | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | completed | Phase 2 | 17 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00770185 | Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | completed | Phase 2 | 35 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT02988817 | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 306 | GenmabINDUSTRY | 6 | Aug 1, 2023 | clinicaltrials |
| NCT04318340 | A Novel Tapered Applicator for Vaginal Vault Brachytherapy | completed | N/A | 21 | Yale UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03339765 | Self-Advocacy Serious Game in Advanced Cancer | completed | N/A | 78 | University of PittsburghOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT01111461 | Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression | completed | Phase 2 | 133 | Eisai Inc.INDUSTRY | 8 | Jun 22, 2023 | clinicaltrials |
| NCT01686256 | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer | completed | Phase 1 | 12 | EndocyteINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT01689714 | Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma | completed | Phase 2 | 16 | EndocyteINDUSTRY | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05914844 | Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development | completed | — | 30 | Manisa Celal Bayar UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT01367002 | Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer | completed | Phase 2 | 61 | Yale UniversityOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT02690766 | Translating Healthy Lifestyle Interventions for Cancer Survivors | completed | N/A | 17 | University of North Carolina, Chapel HillOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT03917147 | Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination | completed | — | 435 | University of Campania Luigi VanvitelliOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04281043 | Quality of Life After Robotic Surgery for Endometrial Cancer(QoL) | completed | — | 64 | Sahlgrenska University HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors(DUET-4) | completed | Phase 1 | 78 | Xencor, Inc.INDUSTRY | 1 | Mar 30, 2023 | clinicaltrials |
| NCT01818739 | Lymph Node Mapping in Patients With Endometrial Cancer | completed | N/A | 204 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT02549989 | Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03366480 | A Study to Assess the Efficacy and Safety of ABTL0812(Endolung) | completed | Phase 1 / Phase 2 | 103 | Ability Pharmaceuticals SLINDUSTRY | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02921269 | Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04246580 | Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer | completed | — | 230 | Università degli Studi dell'InsubriaOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT02025985 | Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies(SIGN) | completed | Phase 2 | 116 | Karyopharm Therapeutics IncINDUSTRY | 2 | Jan 26, 2023 | clinicaltrials |
| NCT04456972 | Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. | completed | N/A | 44 | Poitiers University HospitalOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT03580421 | Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)(AMBU-ENDO) | completed | N/A | 77 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT01679522 | Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer(LESS-E) | completed | N/A | 107 | Asan Medical CenterOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT01414608 | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | completed | Phase 3 | 926 | GOG FoundationNETWORK | 5 | Nov 7, 2022 | clinicaltrials |
| NCT02788708 | Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer | completed | Phase 1 | 26 | Floor BackesOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05542940 | P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer | completed | — | 100 | Hossam Hassan Aly Hassan El SokkaryOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT04120649 | Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma | completed | — | 50 | Assiut UniversityOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT03394027 | ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Aug 23, 2022 | clinicaltrials |
| NCT04334239 | Effectiveness of Care in Certified Cancer Centres in Germany(WiZen) | completed | — | 670,000 | Technische Universität DresdenOTHER | 1 | Aug 23, 2022 | clinicaltrials |
| NCT02977195 | First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors(NP137) | completed | Phase 1 | 70 | Centre Leon BerardOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT04873206 | Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies | completed | — | 80 | Sohag UniversityOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT01470677 | Tachosil for the Prevention of Symptomatic Lymph Cysts | completed | Phase 3 | 220 | Ruhr University of BochumOTHER | 2 | Jul 8, 2022 | clinicaltrials |
| NCT05448586 | Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? | completed | — | 132 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT01672892 | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | completed | Phase 3 | 289 | Radiation Therapy Oncology GroupNETWORK | 4 | Jun 15, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT00376844 | External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer(PORTEC-2) | completed | Phase 3 | 427 | Leiden UniversityOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | completed | Phase 1 | 159 | Incyte CorporationINDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02549209 | Pembro/Carbo/Taxol in Endometrial Cancer | completed | Phase 2 | 46 | Daniela Matei, MDOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05261165 | Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | completed | — | 170 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT02728258 | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 11 | NRG OncologyOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT01307631 | Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Sep 26, 2023source: clinicaltrials